When the optimal is not the best: parameter estimation in complex biological models
Diego Fernandez Slezak, Cecilia Suarez, Guillermo A. Cecchi, Guillermo, Marshall, Gustavo Stolovitzky

TL;DR
This paper explores the challenges of parameter estimation in complex biological models, highlighting that optimal data fit does not always equate to biologically meaningful parameters, and proposes alternative selection criteria.
Contribution
It demonstrates the ruggedness of the cost function landscape in tumor growth models and advocates for selecting parameters based on biological plausibility rather than just optimal fit.
Findings
Cost function landscape is highly rugged with many local minima.
Optimal fit parameters may not be biologically plausible.
Alternative criteria are needed for parameter selection.
Abstract
Background: The vast computational resources that became available during the past decade enabled the development and simulation of increasingly complex mathematical models of cancer growth. These models typically involve many free parameters whose determination is a substantial obstacle to model development. Direct measurement of biochemical parameters in vivo is often difficult and sometimes impracticable, while fitting them under data-poor conditions may result in biologically implausible values. Results: We discuss different methodological approaches to estimate parameters in complex biological models. We make use of the high computational power of the Blue Gene technology to perform an extensive study of the parameter space in a model of avascular tumor growth. We explicitly show that the landscape of the cost function used to optimize the model to the data has a very rugged…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
